Analytics - Page 3 of 11

As the year draws to a close, major analytics firms traditionally share their view on where the medtech industry is heading and what to expect in the near future. We have gone through these reports and distilled the essentials: from the explosive growth of AI in medical devices and the portable tech market to regional regulatory specifics and shifting investment priorities. This article brings together the key figures, insights, and directions that will shape medtech over the coming years.

In April of this year, a group of Toshiba researchers published a landmark article in Nature that may have escaped the attention of our readers. In the article, the engineers and physicists demonstrated how quantum communication could be established between different cities using existing optical network infrastructure. Until now, quantum messages could only be transmitted via special, expensive, and labor-intensive networks. In fact, the “quantum internet” existed primarily on university campuses.

Another unusual “side effect” has been observed with semaglutide — the drug better known as Ozempic and Wegovy. Originally developed for type 2 diabetes, it proved effective for weight reduction, and now appears to benefit treatment of certain cancers. A University of California San Diego study reports that among people with colon cancer who were concurrently taking semaglutide, five-year mortality was 15.5%, whereas among those not taking it the figure was 37.1% — more than twice as high.